Search Results - "Marinaki, S"

Refine Results
  1. 1
  2. 2

    Patients After Kidney Allograft Failure: Immunologic and Nonimmunologic Considerations by Marinaki, S, Skalioti, C, Boletis, J

    Published in Transplantation proceedings (01-11-2015)
    “…Abstract Patients returning to dialysis after kidney transplant failure represent approximately 5%–15% of the population starting hemodialysis. These patients…”
    Get full text
    Journal Article
  3. 3

    PCSK9 and inflammatory biomarkers in the early post kidney transplantation period by Melexopoulou, C, Marinaki, S, Oikonomou, E, Bonios, M J, Theofilis, P, Miliou, A, Siasos, G, Tousoulis, D, Boletis, J N

    “…  Various biomarkers have been studied in the early post-kidney transplantation (post-KTx) period in order to identify potential therapeutic targets for…”
    Get more information
    Journal Article
  4. 4

    Glomerular Diseases and Renal Transplantation: Pathogenic Pathways and Evolution of Therapeutic Interventions by Marinaki, S, Skalioti, C, Boletis, J

    Published in Transplantation proceedings (01-03-2017)
    “…Abstract Glomerular diseases and renal transplantation are the main fields of nephrology in which the immune system plays a prevalent role. Glomerular diseases…”
    Get full text
    Journal Article
  5. 5

    The Importance of Novel Inflammatory Biomarkers in Renal Disease by Marinaki, S, Skalioti, C, Siasos, Gerasimos, Papavassiliou, Athanasios G, Tousoulis, Dimitris, Boletis, J N

    Published in Current medicinal chemistry (01-01-2015)
    “…Kidney disease, whether acute or chronic, represents a major health hazard. Acute kidney injury (AKI) detection is based mainly on serum creatinine, which is…”
    Get more information
    Journal Article
  6. 6

    Glomerular Disease Recurrence in the Renal Allograft: A Hurdle But Not a Barrier for Successful Kidney Transplantation by Marinaki, S, Lionaki, S, Boletis, J.N

    Published in Transplantation proceedings (2013)
    “…Abstract Almost all forms of primary as well as secondary glomerulonephritides may recur after renal transplantation. Recurrence of the original disease is now…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Syndrome of Inappropriate Antidiuretic Hormone Secretion Complicating Systemic Nocardiosis in a Renal Transplant Recipient: A Case Report by Melexopoulou, C., Pavlopoulou, I.D., Zormpala, A., Daikos, G.L., Boletis, J.N., Marinaki, S.

    Published in Transplantation proceedings (01-12-2017)
    “…Infection by Nocardia species is an uncommon cause of severe clinical syndromes, particularly in immunocompromised patients, and solid-organ transplantation is…”
    Get full text
    Journal Article
  9. 9

    Evolution of Renal Function in Renal Allograft Recipients Under Various Everolimus-Based Immunosuppressive Regimens by Skalioti, C, Marinaki, S, Darema, M, Lionaki, S, Antonakopoulos, N, Zavos, G, Boletis, J

    Published in Transplantation proceedings (01-07-2015)
    “…Abstract Background Long-term allograft survival is a major challenge in kidney transplantation. This study sought to estimate the evolution of renal function…”
    Get full text
    Journal Article
  10. 10
  11. 11

    B Cell Depletion: Rituximab in Glomerular Disease and Transplantation by Marinaki, S., Skalioti, C., Boletis, J.N.

    Published in Nephron extra (31-12-2013)
    “…B cells play a central role in the pathogenesis of many autoimmune diseases. Selective targeting can be achieved with the use of the monoclonal antibody…”
    Get full text
    Journal Article
  12. 12

    Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement by Iatrou, C, Zerbala, S, Revela, I, Spanou, E, Marinaki, S, Nakopoulou, L, Boletis, J

    Published in Clinical nephrology (01-07-2009)
    “…Cytotoxic drugs have reduced the mortality in patients with ANCA-associated vasculitis (AASV) but their use carries a substantial risk of toxicity. Efforts are…”
    Get more information
    Journal Article
  13. 13

    Abnormalities of CD4+ T cell subpopulations in ANCA‐associated vasculitis by Marinaki, S., Neumann, I., Kälsch, A.‐I., Grimminger, P., Breedijk, A., Birck, R., Schmitt, W., Waldherr, R., Yard, B. A., Van Der Woude, F. J.

    Published in Clinical and experimental immunology (01-04-2005)
    “…Summary In patients with ANCA‐associated vasculitis (AAV), CD25 expression is increased on circulating T cells. Although in animal experiments the role of CD4+…”
    Get full text
    Journal Article
  14. 14

    In vivo effects of cyclic administration of 15‐deoxyspergualin on leucocyte function in patients with Wegener's granulomatosis by Kälsch, A.‐I., Schmitt, W. H., Breedijk, A., Marinaki, S., Weigerding, S., Nebe, T. C., Nemoto, K., Van Der Woude, F. J., Yard, B. A., Birck, R.

    Published in Clinical and experimental immunology (01-12-2006)
    “…Summary 15‐Deoxyspergualin (DSG) is an alternative treatment modality for Wegener's granulomatosis (WG) patients refractory to conventional treatment…”
    Get full text
    Journal Article
  15. 15

    Altered CD46‐mediated T cell co‐stimulation in haemodialysis patients by Brinkkoetter, P.‐T., Marinaki, S., Gottmann, U., Fleckenstein, S., Stump, C., Van Der Woude, F. J., Braun, C., Yard, B. A.

    Published in Clinical and experimental immunology (01-03-2005)
    “…Summary While most of our understanding of immune dysfunction in dialysis patients involves alterations in CD28–CD80/86 signalling, nothing is known of…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20